HealthEquity, Inc. (HQY) Stock

About HealthEquity, Inc.

HealthEquity, Inc. is led by CEO Scott R. Cutler, employs 2,814 people, headquartered in Draper, US, publicly traded since 2014.

HealthEquity, Inc. (HQY) stock trades at $103.97 with a market capitalization of $8.60B. The stock is valued at a price-to-earnings (P/E) ratio of 31.59, price-to-book of 3.71, price-to-sales of 5.43. Over the past 52 weeks the stock has ranged between $72.76 and $107.62, and currently trades 3.4% below its 52-week high.

On profitability, HealthEquity, Inc. generates a return on equity (ROE) of 11.43%, return on capital employed of 11.19%, an operating margin of 21.64%, a net profit margin of 17.36%.

HealthEquity, Inc. by the numbers, 2017–2026

Between 2017 and 2026 HealthEquity, Inc. reported revenue of $178.0M rising to $1.3B, a change of +637.6% across 10 years. Compounded, revenue has grown 12.3% a year over five years, 15.1% over three, 9.4% over the last twelve months. Net profit rose to $215.0M.

Operating margin went from 23.1% in 2017 to 24.6% in 2026, a gain of 1.4 percentage points. The most recent net margin is 17.36%. On a trailing twelve-month basis to Jun '26, revenue is $1.4B and net profit $237.0M.

Borrowings stand at $1.0B, cash from operations was $457.0M in the latest year, positive in 10 of the last 10.

Return on equity has averaged 2.8% over five years, and was 10.2% in the most recent year.

The share price itself has compounded at 1.6% a year over five years, 13.3% over three, -16.8% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

HealthEquity, Inc. (HQY) — frequently asked questions